Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications.

Johns, Jeffery S; Krogh, Klaus; Ethans, Karen; Chi, Joanne; Querée, Matthew; Eng, Janice J

Johns, Jeffery S; Krogh, Klaus; Ethans, Karen; Chi, Joanne; Querée, Matthew; Eng, Janice J.

Afiliação

Johns JS; Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Krogh K; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus, Denmark.
Ethans K; Physical Medicine and Rehabilitation, University of Manitoba, Winnipeg Health Sciences Centre, Winnipeg, MB R3A 1R9, Canada.
Chi J; Department of Physical Therapy, University of British Columbia and Rehabilitation Research Program, GF Strong Rehab Centre, Vancouver, BC V5Z 2G9, Canada.
Querée M; Department of Physical Therapy, University of British Columbia and Rehabilitation Research Program, GF Strong Rehab Centre, Vancouver, BC V5Z 2G9, Canada.
Eng JJ; Spinal Cord Injury Research Evidence Team, Vancouver, BC V5Z 2G9, Canada.
Spinal Cord Injury Research Evidence Team; Department of Physical Therapy, University of British Columbia and Rehabilitation Research Program, GF Strong Rehab Centre, Vancouver, BC V5Z 2G9, Canada.

J Clin Med ; 10(4)2021 Feb 22.

Article em En | MEDLINE | ID: mdl-33671492

Palavras-chave

multiple sclerosis; neurogenic bowel dysfunction; pharmacological; spinal cord injury; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google